Analbuminaemia
ORPHA: 86816
Overview
Congenital analbuminemia (CAA) is characterized by the absence or dramatic reduction of circulating human serum albumin (HSA)
Available Treatments (0)
No treatments linked yet
Clinical trials or compassionate use may be available — consult a specialist.
Clinical Presentation
Signs and symptoms associated with Analbuminaemia, sourced from HPO and Orphanet clinical annotations.
EdemaHypoalbuminemiaSmall for gestational agePremature birthHypoproteinemiaHyperlipidemiaHypercholesterolemiaElevated circulating alpha-globulin concentrationLipodystrophyIncreased circulating immunoglobulin concentrationPedal edemaFatigueFacial edemaObesityOligohydramniosRecurrent lower respiratory tract infectionsMild global developmental delayLow pulse pressure
Classification & Codes
Orphanet Code
ORPHA:86816Analbuminaemia
| Orphanet | ORPHA:86816 |
| Treatments | 0 drug(s) |
| Symptoms on record | 18 signs |
| Status | published |
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO